Neuropeptide Mixture

Cerebrolysin

Not FDA approvedRecovery & tissue repairBrain, mood & sleepLongevity & cellular
6.3/10

BioHarmony verdict

Worth trying

Cerebrolysin is a porcine brain-derived peptide mixture given by IV or IM infusion. It has the largest human trial base of any nootropic-adjacent peptide, yet the maker-funded positive trials clash with two null-to-negative independent Cochrane reviews, per Ziganshina 2023, which is why it lands at 6.0-6.5/10 (Worth trying).

Read full report

What is Cerebrolysin?

Cerebrolysin is a porcine brain-derived peptide preparation, a mixture of small peptides and free amino acids extracted from pig brain tissue, given by intravenous infusion or intramuscular injection and marketed as neurotrophic, meaning it is meant to act like your body's own nerve growth factors. It is not a single defined molecule, which is unusual for something people inject. It is a biological extract whose batch composition is characterized in the lab but never reduced to one declared active ingredient, per Ziganshina et al. 2023. Cerebrolysin is genuinely interesting and genuinely unresolved at the same time, and pretending otherwise would not help you.

From the BioHarmony report, reviewed 2026-09-08.

How it is thought to work

Claimed neurotrophic, mimicking endogenous growth factors; not a single defined molecule

Safety watch-outs

  • Any sign of an allergic or hypersensitivity reaction to the biological (hives, swelling, wheezing, throat tightness): stop and seek…
  • New seizure, confusion, or a marked worsening of neurological symptoms during a course: stop and consult a clinician.
  • Fever, spreading redness, or pus at an injection or infusion site (possible contamination from grey-market product): stop and seek care.
  • Any active or suspected cancer: do not use a growth-factor-mimicking biological without specialist guidance.

Full risk profile in the BioHarmony report.

Dosing as published

No approved-label or study protocol is recorded for Cerebrolysin yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (3)

Attributed viewpoints, separate from primary research.

Trust & sourcing

US approvalNot FDA approved
CompoundingNo FDA-approved U.S. product is identified in the reviewed source set
Last checked2026-07-13
Next review2027-01-09

Cerebrolysin is a porcine-brain-derived mixture of peptides and amino acids used in some countries. A 2023 Cochrane review found no demonstrated mortality benefit in acute ischemic stroke and reported an increase in non-fatal serious adverse events in some analyses.

Primary sources

  1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
  2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  3. 7.4/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
  4. 7.3/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedFDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.